Hologic Inc
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $71.98
- Today's High:
- $73.21
- Open Price:
- $72.64
- 52W Low:
- $59.78
- 52W High:
- $87.88
- Prev. Close:
- $72.79
- Volume:
- 1581625
Company Statistics
- Market Cap.:
- $17.83 billion
- Book Value:
- 21.156
- Revenue TTM:
- $4.04 billion
- Operating Margin TTM:
- 23.04%
- Gross Profit TTM:
- $3.31 billion
- Profit Margin:
- 11.99%
- Return on Assets TTM:
- 6.22%
- Return on Equity TTM:
- 9.51%
Company Profile
Hologic Inc had its IPO on 1990-06-21 under the ticker symbol HOLX.
The company operates in the Healthcare sector and Medical Instruments & Supplies industry. Hologic Inc has a staff strength of 6,944 employees.
Stock update
Shares of Hologic Inc opened at $72.64 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $71.98 - $73.21, and closed at $72.01.
This is a -1.07% slip from the previous day's closing price.
A total volume of 1,581,625 shares were traded at the close of the day’s session.
In the last one week, shares of Hologic Inc have slipped by -4.14%.
Hologic Inc's Key Ratios
Hologic Inc has a market cap of $17.83 billion, indicating a price to book ratio of 3.826 and a price to sales ratio of 3.7921.
In the last 12-months Hologic Inc’s revenue was $4.04 billion with a gross profit of $3.31 billion and an EBITDA of $1.29 billion. The EBITDA ratio measures Hologic Inc's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Hologic Inc’s operating margin was 23.04% while its return on assets stood at 6.22% with a return of equity of 9.51%.
In Q2, Hologic Inc’s quarterly earnings growth was a negative -51.7% while revenue growth was a negative 1.8%.
Hologic Inc’s PE and PEG Ratio
- Forward PE
- 21.4133
- Trailing PE
- 37.715
- PEG
- 0.9333
Its diluted EPS in the last 12-months stands at $1.93 per share while it has a forward price to earnings multiple of 21.4133 and a PEG multiple of 0.9333. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Hologic Inc’s profitability.
Hologic Inc stock is trading at a EV to sales ratio of 3.9562 and a EV to EBITDA ratio of 9.1031. Its price to sales ratio in the trailing 12-months stood at 3.7921.
Hologic Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $9.34 billion
- Total Liabilities
- $981.30 million
- Operating Cash Flow
- $-38700000.00
- Capital Expenditure
- $36.50 million
- Dividend Payout Ratio
- 0%
Hologic Inc ended 2024 with $9.34 billion in total assets and $0 in total liabilities. Its intangible assets were valued at $9.34 billion while shareholder equity stood at $5.18 billion.
Hologic Inc ended 2024 with $33.10 million in deferred long-term liabilities, $981.30 million in other current liabilities, 3000000.00 in common stock, $1.97 billion in retained earnings and $3.30 billion in goodwill. Its cash balance stood at $2.77 billion and cash and short-term investments were $2.77 billion. The company’s total short-term debt was $31,800,000 while long-term debt stood at $2.79 billion.
Hologic Inc’s total current assets stands at $4.34 billion while long-term investments were $0 and short-term investments were $0. Its net receivables were $686.80 million compared to accounts payable of $180.60 million and inventory worth $680.10 million.
In 2024, Hologic Inc's operating cash flow was $-38700000.00 while its capital expenditure stood at $36.50 million.
Comparatively, Hologic Inc paid $0 in dividends in 2024.
Other key metrics
- Current Trading Price
- $72.01
- 52-Week High
- $87.88
- 52-Week Low
- $59.78
- Analyst Target Price
- $89.93
Hologic Inc stock is currently trading at $72.01 per share. It touched a 52-week high of $87.88 and a 52-week low of $87.88. Analysts tracking the stock have a 12-month average target price of $89.93.
Its 50-day moving average was $76.8 and 200-day moving average was $79.24 The short ratio stood at 2.12 indicating a short percent outstanding of 0%.
Around 73.2% of the company’s stock are held by insiders while 9939.6% are held by institutions.
Frequently Asked Questions About Hologic Inc
Similar Industry Stocks (Medical Instruments & Supplies)
Most Active
Top Gainers
Top Losers
About
Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women’s health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, and human cytomegalovirus; Aptima BV and Aptima CV/TV assays for the diagnosis of vaginitis; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays for the detection of SARS-CoV-2; ThinPrep System for use in cytology applications; and Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth. It also offers solutions for breast cancer care primarily in the areas of radiology, breast surgery, pathology, and treatment, such as 2D and 3D digital mammography systems, image analytics software, reading workstations, ultrasound imaging, minimally invasive breast biopsy guidance systems, breast biopsy site markers, localization, specimen radiology, and ultrasound and connectivity solutions, as well as breast conserving surgery products. In addition, the company provides NovaSure Endometrial Ablation System for the treatment of abnormal uterine bleeding; MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids, polyps, and other pathology in the uterus; Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures; and the CoolSeal portfolio that includes bipolar vessel sealing devices. Further, it offers Horizon DXA, a dual energy X-ray system; and the Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. The company sells its products through direct sales and service forces, and independent distributors and sales representatives. Hologic, Inc. wa